共 33 条
[1]
Fiocchi C., Inflammatory bowel disease: etiology and pathogenesis, Gastroenterol, 115, 1, pp. 182-205, (1998)
[2]
Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., Kaplan G.G., Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterol, 142, pp. 46-54, (2012)
[3]
Triantafillidis K.J., Merikas E., Georgopoulos F., Current and emerging drugs for the treatment of inflammatory bowel disease, Drug Des DevTher, 5, pp. 185-210, (2011)
[4]
Anthony A., Pounder R.E., Dhillon A.P., Wakefield A.J., The inflammatory bowel disease study group, Similarities between ileal Crohn’s disease and indomethacin experimental jejunal ulcers in the rat. Aliment Pharmacol Ther, 14, pp. 241-245, (2000)
[5]
Bonner G.F., Exacerbation of inflammatory bowel disease associated with use of celecoxib, Am J Gastroenterol, 96, 4, pp. 1306-1308, (2001)
[6]
Bonner G.F., Fakhri A., Vennamaneni S.R., A long term cohort study of non steroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease, Inflamm Bowel Dis, 10, pp. 751-757, (2004)
[7]
Tibble J., Teahon K., Thjodleifsson B., Roseth A., Sigthorsson G., Bridger S., Foster R., Sherwood R., Fagerhol M., Bjarnason I., A simple method for assessing intestinal inflammation in Crohn’s disease, Gut, 47, pp. 506-513, (2000)
[8]
Abimosleh S.M., Lindsay R.J., Butler R.N., Cummins A.G., Howarth G.S., Emu oil increases colonic crypt depth in a rat model of ulcerative colitis, Dig Dis Sci, 57, 4, pp. 887-896, (2011)
[9]
Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M., Effect of an enteric coated fish oil preparation on relapses in Crohns disease, New Engl J Med, 334, 24, pp. 1557-1560, (1996)
[10]
Calder P.C., N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?, Nutr Res, 21, pp. 309-341, (2001)